 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Research analysts at StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI Get Free Report) in a note issued to investors on Tuesday. The firm set a hold rating on the biotechnology companys stock. Other analysts also recently issued reports about the company. HC ...

Spectrum Pharmaceuticals (NASDAQ:SPPI) Research Coverage Started at StockNews.com

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI Get Free Report) have earned a consensus recommendation of Hold from the five ratings firms that are currently covering the firm, MarketBeat reports. Five investment analysts have rated the stock with a hold recommendation. The average 12-month ...

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Given Average Recommendation of "Hold" by Brokerages

StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI  Free Report) in a research report released on Tuesday . The brokerage issued a hold rating on the biotechnology companys stock. Several other research firms have also commented on SPPI. HC Wainwright ...

Spectrum Pharmaceuticals (NASDAQ:SPPI) Coverage Initiated by Analysts at StockNews.com

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI  Get Free Report) has been given a consensus recommendation of Hold by the five brokerages that are covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation. The average 1-year price...

Brokerages Set Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Price Target at $2.44

StockNews.com initiated coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI  Free Report) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biotechnology companys stock. A number of other research firms also recently weighed in on SPPI...

Buy Spectrum Pharmaceuticals For Exposure To Assertio Holdings

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum or the Company) announced today that the leading independent proxy advisory firms, Institutional Shareholder Services, Inc. (ISS) and Glass Lewis & Co. (Glass Lewis), have each recommended that Spectrum stockholders vote FOR the...

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote FOR Proposed Transaction with Assertio Holdings, Inc.

StockNews.com began coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI  Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the biotechnology companys stock. Several other research analysts have also recently commented on the company. ...

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI  Free Report)  Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Spectrum Pharmaceuticals in a research note issued on Tuesday, July 11th. Cantor Fitzgerald analyst P. Agrawal expects that ...

Research Analysts Issue Forecasts for Spectrum Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:SPPI)

Stock analysts at StockNews.com assumed coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI  Free Report) in a note issued to investors on Saturday. The firm set a hold rating on the biotechnology companys stock. Other equities analysts have also issued research ...

Spectrum Pharmaceuticals (NASDAQ:SPPI) Coverage Initiated at StockNews.com

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.

Watchers	10,913
52-Wk Low	$0.315
52-Wk High	$1.57

Market Cap	$211.4M
Volume (M)	5.93M
52-Wk High	$1.57
52-Wk Low	$0.315

SPPI Spectrum Pharmaceuticals, Inc.

About

Feed

News

Earnings

Fundamentals